Treatment of the symptoms of Huntington's disease: Preliminary results comparing aripiprazole and tetrabenazine
Identifieur interne : 000925 ( Main/Exploration ); précédent : 000924; suivant : 000926Treatment of the symptoms of Huntington's disease: Preliminary results comparing aripiprazole and tetrabenazine
Auteurs : Livia Brusa [Italie] ; Antonio Orlacchio [Italie] ; Vincenzo Moschella [Italie] ; Cesare Iani [Italie] ; Giorgio Bernardi [Italie] ; Nicola Biagio Mercuri [Italie]Source :
- Movement Disorders [ 0885-3185 ] ; 2009-01-15.
English descriptors
Abstract
Aripiprazole (AP), a dopamine (DA) D2 receptor partial agonist, has recently been used to reduce schizophrenic symptoms, while tetrabenazine (TBZ), a DA depletor, has been used to treat hyperkinesias in Huntington's disease (HD). The aim of this study is to define the role of AP on chorea, motor performance, and functional disability, and to compare the effects of AP vs. TBZ in a small study of six patients with HD. Both AP and TBZ increased the Unified Huntington's Disease Rating Scale (UHDRS) chorea score in a similar way. However, AP caused less sedation and sleepiness than TBZ and was better tolerated by the patients on the trial. Moreover, AP showed a slight but not significant improvement of depression in the patients as compared to TBZ. A larger group of patients and a longer period of observation are an important prerequisite for further evaluations of AP's therapeutic use. © 2008 Movement Disorder Society
Url:
DOI: 10.1002/mds.22376
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Treatment of the symptoms of Huntington's disease: Preliminary results comparing aripiprazole and tetrabenazine</title><author><name sortKey="Brusa, Livia" sort="Brusa, Livia" uniqKey="Brusa L" first="Livia" last="Brusa">Livia Brusa</name></author><author><name sortKey="Orlacchio, Antonio" sort="Orlacchio, Antonio" uniqKey="Orlacchio A" first="Antonio" last="Orlacchio">Antonio Orlacchio</name></author><author><name sortKey="Moschella, Vincenzo" sort="Moschella, Vincenzo" uniqKey="Moschella V" first="Vincenzo" last="Moschella">Vincenzo Moschella</name></author><author><name sortKey="Iani, Cesare" sort="Iani, Cesare" uniqKey="Iani C" first="Cesare" last="Iani">Cesare Iani</name></author><author><name sortKey="Bernardi, Giorgio" sort="Bernardi, Giorgio" uniqKey="Bernardi G" first="Giorgio" last="Bernardi">Giorgio Bernardi</name></author><author><name sortKey="Mercuri, Nicola Biagio" sort="Mercuri, Nicola Biagio" uniqKey="Mercuri N" first="Nicola Biagio" last="Mercuri">Nicola Biagio Mercuri</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:A4EAA2B1C46701DE647AB267806AF6E63F520792</idno><date when="2009" year="2009">2009</date><idno type="doi">10.1002/mds.22376</idno><idno type="url">https://api.istex.fr/document/A4EAA2B1C46701DE647AB267806AF6E63F520792/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">002D82</idno><idno type="wicri:Area/Main/Curation">002A03</idno><idno type="wicri:Area/Main/Exploration">000925</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Treatment of the symptoms of Huntington's disease: Preliminary results comparing aripiprazole and tetrabenazine</title><author><name sortKey="Brusa, Livia" sort="Brusa, Livia" uniqKey="Brusa L" first="Livia" last="Brusa">Livia Brusa</name><affiliation wicri:level="3"><country xml:lang="fr">Italie</country><wicri:regionArea>UOC Neurologia, Ospedale Sant'Eugenio, Rome</wicri:regionArea><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName></affiliation></author><author><name sortKey="Orlacchio, Antonio" sort="Orlacchio, Antonio" uniqKey="Orlacchio A" first="Antonio" last="Orlacchio">Antonio Orlacchio</name><affiliation wicri:level="3"><country xml:lang="fr">Italie</country><wicri:regionArea>Laboratorio di Neurogenetica, CERC‐IRCCS Santa Lucia, Rome</wicri:regionArea><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName></affiliation><affiliation wicri:level="3"><country xml:lang="fr">Italie</country><wicri:regionArea>Dipartimento di Neuroscienze, Università di Roma “Tor Vergata”, Rome</wicri:regionArea><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName></affiliation></author><author><name sortKey="Moschella, Vincenzo" sort="Moschella, Vincenzo" uniqKey="Moschella V" first="Vincenzo" last="Moschella">Vincenzo Moschella</name><affiliation wicri:level="3"><country xml:lang="fr">Italie</country><wicri:regionArea>Dipartimento di Neuroscienze, Università di Roma “Tor Vergata”, Rome</wicri:regionArea><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName></affiliation></author><author><name sortKey="Iani, Cesare" sort="Iani, Cesare" uniqKey="Iani C" first="Cesare" last="Iani">Cesare Iani</name><affiliation wicri:level="3"><country xml:lang="fr">Italie</country><wicri:regionArea>UOC Neurologia, Ospedale Sant'Eugenio, Rome</wicri:regionArea><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName></affiliation></author><author><name sortKey="Bernardi, Giorgio" sort="Bernardi, Giorgio" uniqKey="Bernardi G" first="Giorgio" last="Bernardi">Giorgio Bernardi</name><affiliation wicri:level="3"><country xml:lang="fr">Italie</country><wicri:regionArea>Laboratorio di Neurogenetica, CERC‐IRCCS Santa Lucia, Rome</wicri:regionArea><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName></affiliation><affiliation wicri:level="3"><country xml:lang="fr">Italie</country><wicri:regionArea>Dipartimento di Neuroscienze, Università di Roma “Tor Vergata”, Rome</wicri:regionArea><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName></affiliation><affiliation wicri:level="3"><country xml:lang="fr">Italie</country><wicri:regionArea>Laboratorio di Neurologia Sperimentale, CERC‐IRCCS Santa Lucia, Rome</wicri:regionArea><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName></affiliation></author><author><name sortKey="Mercuri, Nicola Biagio" sort="Mercuri, Nicola Biagio" uniqKey="Mercuri N" first="Nicola Biagio" last="Mercuri">Nicola Biagio Mercuri</name><affiliation wicri:level="3"><country xml:lang="fr">Italie</country><wicri:regionArea>Dipartimento di Neuroscienze, Università di Roma “Tor Vergata”, Rome</wicri:regionArea><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName></affiliation><affiliation wicri:level="3"><country xml:lang="fr">Italie</country><wicri:regionArea>Laboratorio di Neurologia Sperimentale, CERC‐IRCCS Santa Lucia, Rome</wicri:regionArea><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2009-01-15">2009-01-15</date><biblScope unit="volume">24</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="126">126</biblScope><biblScope unit="page" to="129">129</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">A4EAA2B1C46701DE647AB267806AF6E63F520792</idno><idno type="DOI">10.1002/mds.22376</idno><idno type="ArticleID">MDS22376</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Huntington's disease</term><term>aripiprazole</term><term>neuroleptics</term><term>tetrabenazine</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Aripiprazole (AP), a dopamine (DA) D2 receptor partial agonist, has recently been used to reduce schizophrenic symptoms, while tetrabenazine (TBZ), a DA depletor, has been used to treat hyperkinesias in Huntington's disease (HD). The aim of this study is to define the role of AP on chorea, motor performance, and functional disability, and to compare the effects of AP vs. TBZ in a small study of six patients with HD. Both AP and TBZ increased the Unified Huntington's Disease Rating Scale (UHDRS) chorea score in a similar way. However, AP caused less sedation and sleepiness than TBZ and was better tolerated by the patients on the trial. Moreover, AP showed a slight but not significant improvement of depression in the patients as compared to TBZ. A larger group of patients and a longer period of observation are an important prerequisite for further evaluations of AP's therapeutic use. © 2008 Movement Disorder Society</div></front></TEI><affiliations><list><country><li>Italie</li></country><region><li>Latium</li></region><settlement><li>Rome</li></settlement></list><tree><country name="Italie"><region name="Latium"><name sortKey="Brusa, Livia" sort="Brusa, Livia" uniqKey="Brusa L" first="Livia" last="Brusa">Livia Brusa</name></region><name sortKey="Bernardi, Giorgio" sort="Bernardi, Giorgio" uniqKey="Bernardi G" first="Giorgio" last="Bernardi">Giorgio Bernardi</name><name sortKey="Bernardi, Giorgio" sort="Bernardi, Giorgio" uniqKey="Bernardi G" first="Giorgio" last="Bernardi">Giorgio Bernardi</name><name sortKey="Bernardi, Giorgio" sort="Bernardi, Giorgio" uniqKey="Bernardi G" first="Giorgio" last="Bernardi">Giorgio Bernardi</name><name sortKey="Iani, Cesare" sort="Iani, Cesare" uniqKey="Iani C" first="Cesare" last="Iani">Cesare Iani</name><name sortKey="Mercuri, Nicola Biagio" sort="Mercuri, Nicola Biagio" uniqKey="Mercuri N" first="Nicola Biagio" last="Mercuri">Nicola Biagio Mercuri</name><name sortKey="Mercuri, Nicola Biagio" sort="Mercuri, Nicola Biagio" uniqKey="Mercuri N" first="Nicola Biagio" last="Mercuri">Nicola Biagio Mercuri</name><name sortKey="Moschella, Vincenzo" sort="Moschella, Vincenzo" uniqKey="Moschella V" first="Vincenzo" last="Moschella">Vincenzo Moschella</name><name sortKey="Orlacchio, Antonio" sort="Orlacchio, Antonio" uniqKey="Orlacchio A" first="Antonio" last="Orlacchio">Antonio Orlacchio</name><name sortKey="Orlacchio, Antonio" sort="Orlacchio, Antonio" uniqKey="Orlacchio A" first="Antonio" last="Orlacchio">Antonio Orlacchio</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000925 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000925 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:A4EAA2B1C46701DE647AB267806AF6E63F520792
|texte= Treatment of the symptoms of Huntington's disease: Preliminary results comparing aripiprazole and tetrabenazine
}}
| This area was generated with Dilib version V0.6.23. |  |